Faslodex

Known as: Faslodex(ICI 182,780) 
 

Topic mentions per year

Topic mentions per year

1988-2018
0102019882018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
The molecular mechanisms underlying the acquisition of resistance to the antiestrogen Faslodex are poorly understood, although… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2004
2004
Antiestrogens induce both cytostasis (cell cycle arrest) and apoptosis, but the relationship between these end points and the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
The effects of estrogen receptor (ER) ligands on the stability and transcriptional activity of ERbeta in the breast cancer cell… (More)
Is this relevant?
2003
2003
Estrogen influences the development and function of the nervous system through estrogen receptor-dependent changes in gene… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2002
2002
17 beta-Oestradiol (ED when subscript to K) and the phytoestrogen isoflavone genistein (GEN) inhibit glucose transport in human… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?
2002
2002
To identify genes associated with survival from antiestrogens, both serial analysis of geneexpression and gene expression… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
This paper describes the establishment of an antiestrogen-resistant MCF7 breast cancer cell subline (FASMCF) by continuous… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
7Alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (ICI 182,780; Faslodex) is a novel… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND The nonsteroidal antiestrogen tamoxifen is well established as an effective treatment for patients with breast… (More)
Is this relevant?
2000
2000
Anti-oestrogen therapy, tamoxifen in particular, has revolutionised the treatment of breast cancer. However, the partial agonist… (More)
Is this relevant?